In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.

Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, aimed at adults who are not using ...

Growth stocks are still on the menu for 2026. The first few months of 2025 were a roller-coaster ride that threatened to ...